Understand the announced 2025 Part D cap, premiums and payment option. Check covered prescriptions and pharmacies before choosing next year’s plan.
October 14, 2024 · Financial Forte Staff
Historical article: prepared retrospectively using information available as of October 14, 2024.
The Medicare drug-coverage discussion looks different this fall. A major change has been announced for 2025: a $2,000 annual out-of-pocket threshold for covered Part D drugs. That can provide meaningful relief, but it does not make every drug plan equivalent or turn $2,000 into a ceiling on every healthcare expense.[1]
Use this year's enrollment review to understand both the new protection and the plan details that still affect you. Compare your actual prescriptions, pharmacy, premiums and coverage requirements. The useful decision is the plan that fits those needs under the 2025 rules, not simply the one that mentions the new cap most prominently.
Know what changes in January and what the cap covers
The redesigned Part D benefit begins January 1, 2025. It has an annual deductible phase, an initial coverage phase and a catastrophic phase. Once the applicable out-of-pocket threshold is reached, the beneficiary pays no cost-sharing for covered Part D drugs for the rest of that calendar year. The threshold applies across qualifying covered-drug spending, not separately to each prescription.[1]
The standard 2025 deductible is $590, although an individual plan's design may differ. The $2,000 threshold concerns qualifying spending on covered Part D drugs. Premiums, noncovered medications and medical services are not all swept into that amount. Some payments made on your behalf can count under the program's rules, so the plan's accumulation record matters.[1]
This is a 2025 change. It does not retroactively recalculate the prescriptions you bought in 2024, and it should not be used to estimate the remaining costs of this year. Keep the two coverage years separate when reviewing a notice or comparing your experience with a new projection.
The protection also does not guarantee that a particular medication will appear on every plan's formulary, the list of covered drugs. Before relying on the cap for a costly medication, confirm that the medication is covered under the plan and understand any approval requirements.
Add the premium to the comparison
Consider a hypothetical beneficiary, Victor, comparing two standalone Part D plans for 2025. Assume both cover his drugs at the intended pharmacy and both are projected to bring his qualifying out-of-pocket drug spending to $2,000. Plan A charges $35 monthly; Plan B charges $65 monthly. These are invented prices, not actual offers.
Plan A's annual premium is $420, making the illustrated premium-plus-drug amount $2,420. Plan B's annual premium is $780, making that amount $2,780. The difference is $360, equal to the $30 monthly premium difference over twelve months. A common drug-spending threshold does not erase the premium difference.
Those totals exclude other healthcare costs, any applicable income-related premium adjustment and expenses that do not qualify for the Part D threshold. They also assume Victor actually reaches the stated drug-spending amount. Someone with lower needs may pay substantially less in drug cost-sharing, making the specific medication estimates especially important.
Suppose a second person expects $700 in drug cost-sharing under Plan A and $400 under Plan B. Using the same premiums, the totals would be $1,120 and $1,180. Plan A would be $60 lower in that different hypothetical. The right comparison changes with the person and the prescriptions; the higher premium does not tell you the answer by itself.
These calculations do not replace a plan comparison. They show why the premium and the estimated drug costs belong on the same page, with the same coverage year and medication assumptions.
Check access before accepting the estimate
Enter the precise drug, strength, quantity and frequency into the comparison. Review whether the pharmacy is in the plan's network and whether using a preferred pharmacy changes the expected price. Compare a convenient location with a cheaper alternative only if the alternative is realistically usable.
Look for prior authorization, quantity limits and step-therapy requirements. These provisions can affect the process for obtaining coverage even when a drug appears on the formulary. Ask the plan how an existing prescription would be handled and involve the prescribing clinician in treatment questions.
If a drug is not covered, ask about the applicable exception process rather than assuming its full cash price will count toward the new cap. Keep records of the answer and any necessary follow-up. Financial planning should not require independently changing or stopping prescribed treatment.
For someone choosing a Medicare Advantage plan with drug coverage, the drug comparison is only part of the decision. Medical providers, service-area rules and the health plan's cost-sharing also matter. A favorable prescription estimate should not obscure a problem accessing the care you expect to use.[2]
Distinguish a lower annual cost from easier payment timing
A separate option beginning in 2025, the Medicare Prescription Payment Plan, allows people with Part D to spread eligible out-of-pocket prescription costs over the calendar year through their plan instead of paying the full amount at the pharmacy. Participation requires opting in; it is a payment arrangement, not an additional discount on the prescriptions.[3]
That distinction matters for a household facing a large bill early in the year. Spreading payments can ease the immediate cash demand, but the household still needs to budget for the amounts billed. Keep the plan's prescription-payment bill separate from the premium in your budget. Ask the plan for the applicable payment calculation and how bills can change as prescriptions are filled. Do not assume every participant simply pays $2,000 divided by twelve.
For Victor, the decision has two parts: choose appropriate coverage and decide whether the payment option would help manage cash flow. The first addresses coverage and total expected expense; the second addresses when that expense is paid.
Medicare Open Enrollment runs October 15 through December 7, 2024, for reviewing 2025 coverage choices.[2] Gather your medication list, compare the full-year figures and resolve important coverage questions before submitting an election. The new protection can make planning easier when it is understood alongside the costs and conditions that remain.
Related reading
Have more questions about Medicare prescription costs and retirement cash flow? Complete the Financial Forte questionnaire to get started on connecting with an advisor who can help answer your questions and explore next steps.
The contact invitation is current; it does not imply this contact path existed on the historical reference date.
Educational information, not personalized investment, tax, legal or benefits advice. Examples use hypothetical assumptions. Verify current rules and your circumstances before acting.
Sources
- [1] CMS: Final CY 2025 Part D Redesign Program Instructions fact sheet — April 1, 2024; effective January 1, 2025
- [2] CMS: 2025 Medicare Advantage and prescription drug programs — September 27, 2024
- [3] CMS: Medicare Prescription Payment Plan Final Part Two Guidance — July 16, 2024; program begins 2025
